Gleevec (imatinib mesylate) in 16 patients with chronic myelomonocytic leukemia (CMMoL).

被引：0
|
作者：
Raza, A [1 ]
Lisak, L [1 ]
Dutt, D [1 ]
Syed, E [1 ]
Dean, L [1 ]
Fantroy, L [1 ]
Gezer, S [1 ]
Reddy, P [1 ]
Hsu, WT [1 ]
Goldberg, C [1 ]
Loew, J [1 ]
Venugopal, P [1 ]
机构：
[1] Rush Univ, MDS Ctr, Chicago, IL 60612 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4829
引用
收藏
页码：273B / 273B
页数：1
相关论文
共 50 条
  • [21] Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
    Alves, Alexandra Rodrigues
    Lima, William Gustavo
    Nagai, Michelly Martins
    Vilela Rodrigues, Joao Paulo
    Ayres, Lorena Rocha
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 52 (04) : 581 - 589
  • [22] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [23] Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec) - Bone marrow histopathology and correlation with genetic status
    Frater, JL
    Tallman, MS
    Variakojis, D
    Druker, BJ
    Resta, D
    Riley, MB
    Hrisinko, MA
    Peterson, LC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (06) : 833 - 841
  • [24] Deletion of derivative chromosome 9 has no prognostic impact on patients (pts) with chronic myeloid leukemia (CML) treated with imatinib mesylate (Gleevec™).
    Quintas-Cardama, A
    Kantarjian, H
    Talpaz, M
    O'Brien, S
    Garcia-Manero, G
    Hayes, K
    Glassman, A
    Rios, MB
    Shan, J
    Cortes, J
    BLOOD, 2003, 102 (11) : 184A - 184A
  • [25] Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia
    Monique P. Curran
    Katherine F. Croom
    Karen L. Goa
    BioDrugs, 2004, 18 : 207 - 210
  • [26] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [27] Spotlight on imatinib mesylate in chronic myeloid leukemia
    Curran, MP
    Croom, KF
    Goa, KL
    BIODRUGS, 2004, 18 (03) : 207 - 210
  • [28] Imatinib mesylate and treatment of chronic myeloid leukemia
    Yamada, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [29] Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase
    Kiguchi, Toru
    Tauchi, Tetsuzo
    Ito, Yoshikazu
    Miyazawa, Keisuke
    Kimura, Yukihiko
    Ohyashiki, Kazuma
    LEUKEMIA RESEARCH, 2009, 33 (03) : 506 - 508
  • [30] Imatinib mesylate in the treatment of chronic myelogenous leukemia
    Borthakur, G
    Cortes, JE
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (05) : 411 - 419
12345